| Mark T Kraus, MD | |
|
55 Lake Ave N, Department Of Orthopedics, Worcester, MA 01655-0002 | |
| (888) 244-6094 | |
| Not Available |
| Full Name | Mark T Kraus |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 25 Years |
| Location | 55 Lake Ave N, Worcester, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144316647 | NPI | - | NPPES |
| 110086722A | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 245837 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Umass Memorial Medical Center/university Campus | Worcester, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Umass Memorial Medical Group Inc | 4284539891 | 1889 |
News Archive
An international research consortium led by Trinity College Dublin that aims to develop a new Alzheimer's disease treatment has just been selected for grant funding of €6 million by the European Commission Seventh Framework Programme (FP7).
A gene network behind hardening of the arteries and coronary heart disease has been identified by a team of scientists from Australia, Europe and the United Kingdom. Their findings expose potential targets for the treatment of heart disease.
Peregrine Pharmaceuticals, Inc., today announced that noted cancer researcher Bruce Chabner, M.D., will serve as a clinical advisor to the company on the design of clinical trials for the bavituximab cancer program.
By the age of 20, most people have reached skeletal maturity and do not grow any taller. Until recently it was assumed that skeletal enlargement elsewhere in the body also stopped by age 20.
Simulations Plus, Inc., a leading provider of simulation and modeling software for pharmaceutical discovery and development, has announced the launch of its MedChem Studio™ software for drug discovery.
› Verified 8 days ago
| Entity Name | Umass Memorial Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760445373 PECOS PAC ID: 4284539891 Enrollment ID: O20040113000267 |
News Archive
An international research consortium led by Trinity College Dublin that aims to develop a new Alzheimer's disease treatment has just been selected for grant funding of €6 million by the European Commission Seventh Framework Programme (FP7).
A gene network behind hardening of the arteries and coronary heart disease has been identified by a team of scientists from Australia, Europe and the United Kingdom. Their findings expose potential targets for the treatment of heart disease.
Peregrine Pharmaceuticals, Inc., today announced that noted cancer researcher Bruce Chabner, M.D., will serve as a clinical advisor to the company on the design of clinical trials for the bavituximab cancer program.
By the age of 20, most people have reached skeletal maturity and do not grow any taller. Until recently it was assumed that skeletal enlargement elsewhere in the body also stopped by age 20.
Simulations Plus, Inc., a leading provider of simulation and modeling software for pharmaceutical discovery and development, has announced the launch of its MedChem Studio™ software for drug discovery.
› Verified 8 days ago
| Entity Name | Reliant Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720017528 PECOS PAC ID: 5597755322 Enrollment ID: O20040708000650 |
News Archive
An international research consortium led by Trinity College Dublin that aims to develop a new Alzheimer's disease treatment has just been selected for grant funding of €6 million by the European Commission Seventh Framework Programme (FP7).
A gene network behind hardening of the arteries and coronary heart disease has been identified by a team of scientists from Australia, Europe and the United Kingdom. Their findings expose potential targets for the treatment of heart disease.
Peregrine Pharmaceuticals, Inc., today announced that noted cancer researcher Bruce Chabner, M.D., will serve as a clinical advisor to the company on the design of clinical trials for the bavituximab cancer program.
By the age of 20, most people have reached skeletal maturity and do not grow any taller. Until recently it was assumed that skeletal enlargement elsewhere in the body also stopped by age 20.
Simulations Plus, Inc., a leading provider of simulation and modeling software for pharmaceutical discovery and development, has announced the launch of its MedChem Studio™ software for drug discovery.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark T Kraus, MD Po Box 415348, Boston, MA 02241-5348 Ph: (800) 225-8885 | Mark T Kraus, MD 55 Lake Ave N, Department Of Orthopedics, Worcester, MA 01655-0002 Ph: (888) 244-6094 |
News Archive
An international research consortium led by Trinity College Dublin that aims to develop a new Alzheimer's disease treatment has just been selected for grant funding of €6 million by the European Commission Seventh Framework Programme (FP7).
A gene network behind hardening of the arteries and coronary heart disease has been identified by a team of scientists from Australia, Europe and the United Kingdom. Their findings expose potential targets for the treatment of heart disease.
Peregrine Pharmaceuticals, Inc., today announced that noted cancer researcher Bruce Chabner, M.D., will serve as a clinical advisor to the company on the design of clinical trials for the bavituximab cancer program.
By the age of 20, most people have reached skeletal maturity and do not grow any taller. Until recently it was assumed that skeletal enlargement elsewhere in the body also stopped by age 20.
Simulations Plus, Inc., a leading provider of simulation and modeling software for pharmaceutical discovery and development, has announced the launch of its MedChem Studio™ software for drug discovery.
› Verified 8 days ago
Wayne Wayfu Chan, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 119 Belmont St, Worcester, MA 01605 Phone: 508-334-9750 Fax: 508-334-9762 | |
Thomas J Kesman, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 123 Summer St, Ste 320, Worcester, MA 01608 Phone: 508-368-3140 Fax: 508-368-3143 | |
Matthew Deren, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 119 Belmont St, Worcester, MA 01605 Phone: 508-334-9750 Fax: 508-334-9762 | |
Christina G Kane, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 55 Lake Ave N, Worcester, MA 01655 Phone: 508-334-1000 | |
Dr. Mary Ann Badon, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 55 Lake Ave North, Worcester, MA 01655 Phone: 508-334-1000 | |
Christopher Jay Vinton, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 59 Quinsigamond Ave, Worcester County Orthopedics, Worcester, MA 01610 Phone: 508-755-1123 Fax: 508-755-5640 | |
Brian Burroughs, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 123 Summer St Ste 320, Worcester, MA 01608 Phone: 508-964-5580 Fax: 508-368-3143 |